NCT06237647 is a NA clinical trial of Hyaluronic acid, HA in Rotator Cuff Lesions, sponsored by Tien-Ching Lee.

Who is sponsoring NCT06237647?

NCT06237647 is sponsored by Tien-Ching Lee.

What drugs are being tested in NCT06237647?

Interventions in NCT06237647: Hyaluronic acid, HA.

What condition does NCT06237647 study?

NCT06237647 studies Rotator Cuff Lesions.

Is NCT06237647 still recruiting?

NCT06237647 is currently recruiting now. Last updated 5 March 2025.

Last reviewed 2025-03-05 · How we verify

NCT06237647

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Steroid, PRP,and PRP Plus Hyaluronic Acid Injection for Rotator Cuff Lesions.

Recruiting now NA Last updated 5 March 2025

What this trial tests

NA trial testing Hyaluronic acid, HA in Rotator Cuff Lesions in 80 participants. Currently enrolling.

Timeline

17 February 2023

Primary endpoint
30 December 2027

31 December 2027

Quick facts

Lead sponsor	Tien-Ching Lee
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	80
Start date	17 February 2023
Primary completion	30 December 2027
Estimated completion	31 December 2027
Sites	1 location across Taiwan

Drugs / interventions tested

Hyaluronic acid, HA

Conditions studied

Rotator Cuff Lesions — all drugs for Rotator Cuff Lesions →

Sponsor

Tien-Ching Lee

Who can join

Adults 20 to 85, any sex, with Rotator Cuff Lesions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Rotator cuff tear is a common cause of shoulder pain. Steroids, hyaluronic acid (HA), and platelet-rich plasma (PRP) injections are becoming popular for the treatment of chronic rotator cuff partial tear. The investigators plan to evaluate the effect of the new product of PRP combined with HA on the rotator cuff and prove its benefit of pain control and function recovery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06237647 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tien-Ching Lee
Last refreshed: 5 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06237647.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing